Home » Topics » BioWorld Science

BioWorld Science
RSS

LEO Pharma initiates phase I study of LEO-138559

July 2, 2018

JCR initiates phase II study of JR-141 as treatment of Hunter syndrome in Brazil

July 2, 2018

EMA committee recommends marketing authorization for Veyvondi

July 2, 2018

IMpassion130 study of Tecentriq plus Abraxane meets primary endpoint

July 2, 2018

Lynparza receives Japanese approval for BRCA-mutated metastatic breast cancer

July 2, 2018

CHMP adopts positive opinion for Yescarta

July 2, 2018

Phase II results presented from pivotal CAPTIVATE trial of ibrutinib plus venetoclax

July 2, 2018

Refixia obtain Japanese approval for the treatment of hemophilia B

July 2, 2018

Kymriah granted positive CHMP opinion for the treatment of two aggressive blood cancers

July 2, 2018

Patient enrollment ongoing in phase I/II study of SOBI-003 in pediatric MPS IIIA

July 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...